If you know someone at risk for Alzheimer’s disease, they may be eligible for a clinical research study.
Your brain may show signs of Alzheimer’s disease before you notice any changes in your memory or ability to think clearly. Those at risk may prequalify for a clinical research study on Alzheimer’s Disease.
In order to meet study eligibility criteria, participants must:
- Be 55 to 80 years of age
- Have normal memory, thinking, mood and behavior patterns
- Have a reliable study partner* who knows you and is willing to attend appointments with you throughout the study
- Meet additional study requirements
The study involves people who have normal memory, thinking, mood and behavior patterns. Participants are randomly assigned to one of two groups. They receive either the investigational drug or a placebo. Those who receive placebo may have the option to receive the investigational drug at a later time.
If you qualify, participation can last as long as approximately 4.5 years, but will vary for each participant. All study appointments will be conducted either in person or as a virtual appointment, through a video call, depending on the purpose of the visit.
The main objective of a clinical research study is to answer questions about the safety and effectiveness of potential new medications. These studies must be completed before a new treatment can be offered to the public.